With support from USAID, the nonprofit TB Alliance has developed a new treatment for highly drug-resistant forms of tuberculosis. Learn more.
Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.
GHTC's US Policy Officer Emily Conron spoke with Healio Infectious Disease News about the disastrous impact the President's proposed budget cuts could have on global health R&D.
Devex featured an op-ed from GHTC's Director Jamie Bay Nishi making a case that to achieve healthy lives for all, we need a "one-two punch" of innovation and access.
To celebrate Valentine’s Day, GHTC staff embraced our health policy wonkiness by participating in the time-honored beltway tradition, #HealthPolicyValentines, to share our passion for global health R&D. Check out our favorites.
